Hemodynamic stabilization of the patient in septic shock by elimination of inflammatory mediators with hemoadsorption

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032509

Enrollment

Registered

2023-12-01

Start date

2023-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R57.2

Interventions

Group 1: One study group, no control group no randomization, no blinding Treatment after in-house SOP Sepsis according to guidelines, indication for hemoadsorption procedures according to Cyto-Score,

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of septic shock Vasopressor requirement (noradrenaline > 0.3 µg/kg/min), if necessary plus vasopressin Lactate serum concentration ( > 2 mmol/l) Procalcitonin (PCT) > 3 µg/l CytoScore after 6 hours > 6 points

Exclusion criteria

Exclusion criteria: Contraindications for the use of the respective procedures (according to approval)

Design outcomes

Primary

Measure	Time frame
Hemodynamic stabilization within 72 hours after starting CytoSorb	—

Secondary

Measure	Time frame
No secondary endpoint	—

Countries

Germany

Contacts

Public ContactJochen Schmitt

Gemeinschaftsklinikum Mittelrhein (GKM), Standort Ev. Stift, Klinik für Intensivmedizin

neringa95@web.de0261 - 137 -7839

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026